Tolosa & #8211;Hunt syndrome: Long-term outcome and role of steroid-sparing agents
Conclusions: Around 50% of patients with THS can have recurrence. Steroid-sparing agents appear to prevent recurrence. A prospective multicenter randomized controlled trial may help to evaluate the risk and benefits of steroid-sparing therapy and to identify any possible predictors for recurrence.
Source: Annals of Indian Academy of Neurology - Category: Neurology Authors: Anupriya Arthur Ajith Sivadasan Pavitra Mannam AT Prabakhar Sanjith Aaron Vivek Mathew M Karthik Rohith Ninan Benjamin Shaikh Atif Iqbalahmed Gideon Lyngsyun Rynjah Mathew Alexander Source Type: research
More News: Academies | Brain | Cancer & Oncology | India Health | MRI Scan | Neurology | Opthalmology | Pain | Study | Teaching | Teaching Hospitals | Universities & Medical Training